Grann Pharmaceuticals

Advanced Nucleic Acid Therapeutics

Our Vision

At Grann Pharmaceuticals, our commitment to the research and development of mRNA lipid nanoparticles drives us to continuously push the boundaries of what is possible in the current field of nanotechnology, delivering innovative small molecule treatments to create a positive impact on the lives of people worldwide.

Alzheimer's

We are nearing the completion of pre-clinical trials for our Alzheimer's therapeutic, and our goal is to progress it to Phase 1 trials in late 2024.

More than

6 MILLION

Americans are living with Alzheimer's

Methodology

mRNA combined with lipid nanoparticle technology allows for the insertion of lost human proteins back into the human body intravenously.

Lipid Nanoparticle Manufacturing

At Grann Pharmaceuticals, we specialize in creating tailored Lipid Nanoparticles to address stability and delivery issues faced by pharmaceutical, supplement, and research organizations.

Our advanced nano-technology enhances the stability and effectiveness of your company's product, resulting in elevated bioavailability and delivery.